Upgrade to SI Premium - Free Trial

KaloBios Pharma (KBIO) In Discussions with Shkreli Group About Continuing Operations

November 19, 2015 6:22 AM
KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) announced that it has been informed that an investor group comprised of Martin Shkreli and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

13Ds Corporate News Hot Corp. News Hot Insider Trades Insider Trades Momentum Movers Trader Talk

Next Articles